A like-for-like comparison for Knee Osteoarthritis — invasiveness, recovery, evidence level and real cost, side by side, so you can see exactly where each option fits.
Direct answer: For Knee Osteoarthritis, Knee replacement (arthroplasty) is the proven, regulator-backed option (evidence: Strong) but is more invasive (high) with a longer recovery (3–6 months; highly effective). Stem-cell therapy is less invasive (medium) and cheaper (€4,000–15,000 vs €15,000–35,000), but it is investigational — best considered for earlier-stage disease or when you want to delay or avoid surgery, ideally inside a registered trial.
| Option | Evidencia | Indicative cost | Invasiveness | Recovery |
|---|---|---|---|---|
| Stem-cell therapy | Investigational | €4,000–15,000 | Medium | 2–4 weeks; ongoing studies |
| Knee replacement (arthroplasty) | Strong | €15,000–35,000 | High | 3–6 months; highly effective |
First-line management includes weight management and physiotherapy to strengthen supporting muscles and improve biomechanics. Non-steroidal anti-inflammatory drugs (NSAIDs)—ibuprofen, naproxen—reduce pain and inflammation; some individuals use topical creams instead. For moderate OA, intra-articular injections provide targeted relief: corticosteroid injections reduce inflammation for 3–6 weeks, while hyaluronic-acid (viscosupplementation) injections mimic natural joint fluid and may improve symptoms for several months. Walking aids and knee braces reduce load. Advanced cases may require joint replacement (arthroplasty), which is highly effective but invasive. Regular activity, warm water therapy, and weight loss are foundational for all stages.
Regenerative therapies, particularly stem-cell and cartilage-regeneration approaches, are being investigated for knee OA. Bone-marrow-derived or adipose-derived mesenchymal stem cells may promote cartilage repair and reduce inflammation; several clinical trials are ongoing. These treatments remain largely investigational and are not standard care. Candidates may be those with early-to-moderate OA who have not responded adequately to conventional options. See <a href="../treatments/knee-osteoarthritis.html">stem-cell options for knee OA</a> and <a href="../am-i-a-candidate.html">eligibility criteria</a>.
Neither is universally better. Knee replacement (arthroplasty) has the strongest evidence and is definitive, but it is invasive with a 3–6 months; highly effective recovery. Stem-cell therapy is less invasive and cheaper, but unproven — it suits earlier-stage cases or patients avoiding surgery. The right choice depends on your stage, age and goals.
Indicatively €4,000–15,000 for stem-cell therapy versus €15,000–35,000 for Knee replacement (arthroplasty) — but cost should never be the deciding factor for an investigational treatment. Always verify GMP certification and approval status first.
No — for Knee Osteoarthritis it is investigational, not an approved cure. Knee replacement (arthroplasty) is the established standard of care. Check whether a registered ClinicalTrials.gov trial is open before paying for private treatment.
Medicina regenerativa certificada GMP en el corazón de la UE — desde 3.000–8.000 €, una fracción de los precios de EE. UU. o Alemania. Protocolos personalizados para pacientes de más de 50 países.
Evaluación médica gratuita